MRI screening of women with hereditary predisposition to breast cancer: diagnostic performance and survival analysis

Breast Cancer Research and Treatment

Volumn 147, Issue 3, 2014, Pages 685-687

  Santoro, Filippo ^a   Podo, Franca ^a   Sardanelli, Francesco ^b  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

BRCA1 2; Breast cancer screening; High risk; Magnetic resonance imaging

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

BREAST CANCER; CANCER GRADING; CANCER SCREENING; CANCER SURVIVAL; CLINICAL FEATURE; CLINICAL PROTOCOL; COHORT ANALYSIS; DIAGNOSTIC ACCURACY; DISEASE FREE SURVIVAL; EARLY DIAGNOSIS; GENE MUTATION; GENETIC PREDISPOSITION; HETEROZYGOTE; HIGH RISK PATIENT; HUMAN; LETTER; LYMPH NODE METASTASIS; MAMMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; TUMOR INVASION; CARCINOMA, DUCTAL, BREAST; FEMALE; PROCEDURES;

CARCINOMA, DUCTAL, BREAST; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY;

EID: 84918491315     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-014-3097-1     Document Type: Letter

References (11)

1. Gareth ED, Nisha K, Yit L et al (2014) MRI breast screening in high-risk women: cancer detection and survival analysis. Breast Cancer Res Treat 145:663–672
2. Sardanelli F, Podo F, D’Agnolo G et al (2007) Multicenter comparative multimodality surveillance of women at genetic-familial high risk for breast cancer (HIBCRIT Study): interim results. Radiology 242:698–715
3. Sardanelli F, Podo F, Santoro F et al (2011) Multicenter surveillance of women at high genetic breast cancer risk using mammography, ultrasonography, and contrast-enhanced magnetic resonance imaging (the High Breast Cancer Risk Italian 1 study). Final results. Invest Radiol 46:94–105
4. Perou CM, Sørlie T, Eisen MB et al (2000) Molecular portraits of human breast tumors. Nature 406:747–752
5. Kuhl CK, Schrading S, Leutner CC et al (2005) Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol 23:8469–8476
6. Warner E, Plewes DB, Hill KA et al (2004) Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 292:1317–1325
7. Leach MO, Boggis CR, Dixon AK et al (2005) Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet 365:1769–1778
8. Hagen AI, Kvistad KA, Maehle L et al (2007) Sensitivity of MRI versus conventional screening in the diagnosis of BRCA-associated breast cancer in a national prospective series. Breast 16:367–374
9. Riedl CC, Ponhold L, Flöry D et al (2007) Magnetic resonance imaging of the breast improves detection of invasive cancer, preinvasive cancer, and premalignant lesions during surveillance of women at high risk for breast cancer. Clin Cancer Res 13:6144–6152
10. Rijnsburger AJ, Obdeijn IM, Kaas R et al (2010) BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC Screening Study. J Clin Oncol 28:5265–5273
11. Kuhl CK, Weigel S, Schrading S et al (2010) Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial. J Clin Oncol 28:1450–1457